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ABSTRACT
Connective tissue diseases (CTD), such as systemic sclerosis (SSc), systemic lupus erythematosus (SLE),
and mixed connective tissue disease (MCTD), develop pulmonary hypertension (PH). Generally all PH cases
associated with any CTD are classified into the same PH group. However, histological examination shows both
common and specific lesions for each disease. In patients with SLE, fibrosis is generally rare and mild. The
findings of PH in SLE are similar to those in primary pulmonary hypertension. Many cases of SSc are accompa-
nied by fibrosis. MCTD is rather close to SSc. Arterial and arteriolar lesions of MCTD are characterized by fi-
brous intimal thickening. In this review, we describe the pathological features of PH associated with each CTD.
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INTRODUCTION
Connective tissue diseases (CTD) demonstrate vari-
able features and severity of lung involvement. Inter-
stitial pneumonia and pulmonary hypertension (PH)
are considered to be particularly serious complication
of CTD, leading to death.1,2 Currently, PH is classi-
fied according to the Dana Point classification,3 which
was a revision in 2008 of the classification proposed at
the World Symposium on Pulmonary Arterial Hyper-
tension in 2003.
The main CTD that develop PH are systemic scle-
rosis (SSc), systemic lupus erythematosus (SLE),
and mixed connective tissue disease (MCTD). The
incidence has been reported to be 2.6-12.3% in SSc pa-
tients, 0.9-10.5% in SLE patients, and 5-14% in MCTD
patients.4-7 Compared with the incidence of primary
pulmonary hypertension (PPH), which is 1-3 per 1
million people, the incidence in CTD is extremely
high. PH is a serious life-threatening complication in
SSc, MCTD, and SLE.
Histopathological examination of cases with PH in
SSc, MCTD, and SLE shows both common and spe-
cific lesions for each disease. However, all PH cases
associated with any CTD are classified into the same
PH group, and are currently treated based on a com-
mon concept. Plexogenic arteriopathy, often encoun-
tered in PPH can be seen in SLE, but is rarely ob-
served in SSc and MCTD. In addition, fibrinoid vascu-
litis with deposition of immunoglobulins is often
found in PH associated with SLE, but is rare in
MCTD and is never seen in SSc. Therefore, this sug-
gests that the pathogenesis of PH is somewhat differ-
ent in each of these CTD. In this review, we describe
the pathological features of each CTD from autopsy
cases.
FEATURES AND SEVERITY OF PULMO-
NARY VASCULAR LESIONS OF PH IN CTD
Figure 1 shows the results of the analysis of pulmo-
nary lesions in 26 patients with SLE, 14 patients with
SSc, 21 patients with polymyositisdermatomyositis
(PMDM), and 15 patients with MCTD who were
studied by the Research Committee for MCTD of the
Ministry of Health, Labour and Welfare.8 The vertical
axis of each graph represents the grade of pulmonary
fibrosis (PF) ranging (-)-(4+) and the horizontal axis
indicates the grade of hypertensive pulmonary vascu-
lar disease (HPVD) ranging 0-6. Severe HPVD was
encountered in 3 of 26 patients with SLE, but fibrosis
was rare. In patients with SSc, 7 had grades of (2+)-
(4+) and all patients had grades up to HPVD3. There-
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Fig.　1　HPVD and PF in CTD. These are all autopsy cases. In SLE, pulmonary fi ndings 
are defi ned by acute DAD (23 cases) and vascular type (3 cases), not by fi brosis. From 
14 SSc cases, 7 died of pulmonary fi brosis, not severe HPVD. From 15 MCTD cases, 9 
died of HPVD and 4 died of PF. In PM/DM the pattern was rather similar to SSc. From 
above data the pulmonary fi ndings of MCTD were characterized by vascular patterns that 
were different from those of SLE and SSc.
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fore, fibrosis was relatively dominant in SSc. MCTD
demonstrated characteristic features. The majority of
patients, 9 of 15, had vascular lesions of HPVD.
FEATURES OF THE VARIOUS CTD
While CTD with PH show common findings, SLE,
SSc, and MCTD with PH demonstrate individual
characteristics, and cases with MCTD have findings
common to both SLE and SSc, although the charac-
teristics are slightly closer to SSc, as described
above.
HISTOPATHOLOGICAL CHARACTERISTICS OF
PH IN SLE
Pulmonary fibrosis is generally rare and if found in
patients with SLE, the fibrosis is mild, based on
autopsy findings. When patients with SLE die of res-
piratory failure, it is typically due to acute diffuse al-
veolar damage or hemorrhage, but fibrosis is rarely
seen. Therefore, the incidence of PH is generally low.
However, the findings of PH in SLE are similar to
those in PPH, i.e., plexogenic arteriopathy or fibri-
noid vasculitis (Fig. 2). Although the incidence of PH
is low, the grade of PH is generally higher in SLE
than in SSc.
HISTOPATHOLOGICAL CHARACTERISTICS OF
PH IN SSc
Fibrinoid vasculitis or plexogenic arteriopathy is
rarely seen in SSc. Characteristic findings in this dis-
ease are fibrous intimal thickening of medium-sized
arteries and branching small vessels (Fig. 3a). Some
cases also show luminal narrowing or obstruction
throughout the peripheral vessels, which appear to
impair gas exchange (Fig. 3b). Many cases of SSc are
accompanied by fibrosis with impaired blood flow re-
sulting in severe respiratory failure. Therefore, PH in
SSc progresses and is more severe than that of SLE
or ordinary MCTD, as described below.
HISTOPATHOLOGICAL CHARACTERISTICS OF
PH IN MCTD
Although MCTD is considered to have intermediate
or mixed characteristics between SLE and SSc, his-
tologically it is rather close to SSc as regards skin,
esophageal, and kidney lesions. Therefore, MCTD
has been called ‘undeveloped SSc’. However, arterial
and arteriolar lesions of MCTD are characterized by
fibrous intimal thickening but fibrinoid vasculitis or
plexogenic arteriopathy are rare (Fig. 4). The inci-
dence of mixed type of both vascular type and inter-
stitial type is very low.
THE CHARACTERISTICS AND CAUSES OF
PH IN MCTD
Among the CTD, MCTD shows a high incidence of
PH with severe grade in pulmonary arteries. In
MCTD, PH accounts for 16.7% of deaths.9 Here, we
would like to delineate the pathology of MCTD fur-
ther. Figure 5 shows the relationship between HPVD
and pulmonary fibrosis in 17 autopsy cases of
MCTD.10 The 10 cases indicated by the filled circles
died of PH. PH encountered in MCTD consists of vas-
cular type, interstitial type, and mixed type, which
has features of both vascular and interstitial types.
While the incidence of PH is very low in human dis-
Pulmonary Hypertension in CTD
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Fig.　2　Pulmonary vascular lesions in SLE. a) Vasculitis involving adventitia of artery in medium 
sized vessels (Elastica-Goldner stain). b) Fibrinoid arteritis of a medium sized artery with luminal 
narrowing (Elastica-Goldner stain). c) Vasculitis involving all layers of a medium sized artery with 
luminal narrowing (Elastica-Goldner stain). These are all different cases with no severe fi brosis. 
Generally in cases of SLE with severe PH, fi brosis is not so prominent, but diffuse alveolar dam-
age (DAD) with hemorrhage is often seen accompanied by severe vascular lesion such as plexo-
genic arteriopathy and fi brinoid arteritis.
Fig.　3　Pulmonary vascular lesions in SSc. a) Fibrous occlusion or severe intimal thickening of 
medium to small sized arteries (Elastica-Goldner stein). b) Fibrous occlusion of medium sized ar-
teries with collapse of small vessels impairing gas exchange in the alveolar region, or severe inti-
mal thickening of small arteries that are partly occlusive (Elastica-Goldner stein). Above two fi g-
ures, a and b, both belong to the vascular type without fi brosis. These pathologic fi ndings are 
different from SLE, and SSc seldom show fi brinoid arteritis in the lung.
eases, it is fairly high in MCTD.
We examined histologically the autopsy cases
where cause of death was PH associated with MCTD.
Intimal thickening starting from the large vessels and
spreading to the peripheral vessels is characteristic in
severe PH cases. On the other hand, intimal thicken-
ing and thrombosis of the small blood vessels about
100 μm in diameter was also seen in the lungs of al-
most all patients who did not die of PH.11 These find-
ings suggest that slight endothelial damage progres-
Sasaki N et al.
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Fig.　4　Pulmonary vascular lesions in MCTD. a) Severe intimal fi brosis almost occluding the vas-
cular lumen (Elasitica-Goldner stain). b) Organized thrombus in medium sized artery (Elasitica-
Goldner stain). c) Plexogenic arteriopathy sometimes occured (Elasitica-Goldner stain). d) 
Vasculitis of small vessels with infl ammatory infi ltration around vessels almost composed of lym-
phocytes (Elastica-Goldner stain). MCTD cases with PH also show the interstitial type and vascu-
lar type and mixed type with both lesions; however the mixed type is very rare. Further, the vascu-
lar type of MCTD shows similar lesion to SSc such as fi brous thickening and to SLE such as 
plexogenic arteriopathy.
Fig.　5　Histopathological analysis of pulmonary vascular lesions in MCTD. The fi lled cir-
cle represents a patient with fetal PH, and the open circles represent patients who died of 
other causes besides PH such as respiratory insufficiency. We found that out of 15 au-
topsy cases with MCTD, 10 died of HPVD, more than 60% of the patients.
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sively leads to severe vascular lesions (Fig. 6).
Based on the good correlation between pulmonary
pressure and the grade of vascular lesions, the de-
gree of luminal obstruction regarding the size of the
pulmonary vessels was measured using a grading
system of 1-4.11 The results are shown as a schematic
in Figure 7. It appears that endothelial injury firstly
occurs in the small blood vessels in MCTD regard-
less of the presence or absence of PH clinically. Overt
symptoms occur as a result of growth of small
thrombi or intimal thickening. Therefore, we assume
the existence of antibodies to endothelial cells of the
small vessels, i.e., anti-endothelial cell antibodies
(AECA).
The serum AECA levels in patients with MCTD
were measured by flow cytometric analysis using hu-
man pulmonary microvascular endothelial cells. The
results showed that AECA levels were higher in the
Pulmonary Hypertension in CTD
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Fig.　6　Pulmonary vascular lesions in MCTD without PH. Organized thrombus or intimal thicken-
ing, resulting in partial obstruction of small vessels of less than 100 μm in size (a: Hematoxylin-
Eosin stain, b, c, and d: Elastica-Goldner stain). Even in MCTD cases without complicating PH, 
vascular changes such as intimal thickening or organized thrombus occurs in small vessels. 
Whether intimal thickening or small thrombus is present or not, endothelial injury occurs in small 
vessels in MCTD, which may be the fi rst step for severe vascular lesions seen in PH.
Fig.　7　Grade and distribution of vascular lesions of pulmonary vessels in autopsy cases of MCTD. 
Cases with overt clinical PH show severe intimal thickening from artery to vein. Cases without clinical PH 
are characterized by involvement of small vessels. Our data suggest that vascular changes occur fi rst in 
the small vessels in almost all cases, then some advance to PH with HPVD.
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serum of patients with MCTD who presented with
PH clinically (MCTD-PH) than in healthy people or in
patients with MCTD without PH (MCTD-nonPH)
(Fig. 8).12
SUMMARY OF PH ASSOCIATED WITH
HISTOPATHOLOGICAL FINDINGS IN CTD
There are considered to be 2 possible causes of hy-
pertension in the pulmonary circulation characterized
Sasaki N et al.
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Fig.　8　Fluorescence intensity of fl ow cytometric analysis of serum levels of AECA 
against pulmonary microvascular endothelial cells in healthy controls and PH patients. 
MCTD cases demonstrate more intense pattern than healthy controls (red line) (a, b). 
Cases with PH show higher intensity than healthy controls and non-PH cases. MCTD-un 
indicates untreated patients in very early stage (c).
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by a low pressure system. One is a functional mecha-
nism, such as spasms of blood vessels due to hypoxia
that was proven by many experimental studies.13
Also, many individuals who live in high altitudes as in
the Andes region of South America demonstrate PH.
Some cases of PH associated with CTD are known as
the functional type and these are believed to respond
to drug and oxygen therapy better than the organic
type described below. Because blood pressure (P) is
calculated by following the formula: blood flow vol-
ume (V) x resistance (R), P increases as V increases.
This phenomenon is usually seen in cases of left-to-
right shunt with congenital heart diseases, such as
ventricular septal defect, atrial septal defect, and pat-
ent ductus arteriosus. However, we will not deal with
the pulmonary circular dynamism further here.
The other cause of PH is an organic change, which
leads to an increase of vascular resistance (R) in the
above formula. There are 2 major types of PH related
to an elevation of R. One is the interstitial type that is
accompanied by severe fibrosis of medium to small
blood vessels, resulting in an increase of R. The arter-
ies affected by fibrosis show secondary changes of se-
vere intimal thickening called endarteritis. Many pa-
tients with this type of PH die of respiratory failure,
rather than circulatory disturbance, before advance to
severe PH.
The other type of PH is the primary vascular dis-
ease accompanied by severe fibrosis. This type is
called vascular type of PH and is accompanied by
plexogenic arteriopathy or severe fibrous intimal
thickening, occasionally almost occlusive, which
shows findings similar to PPH. This type generally
has more severe vascular lesions compared with that
of the interstitial type. Luminal occlusion of medium
to small arteries induces the collapse of peripheral ar-
teries resulting in impairment of gas exchange in
spite of absence of severe fibrosis.
Immunological abnormalities have been consid-
ered as one of major pathogenic factors of PH in
CTD. Even in PPH, immunological abnormalities are
reported in 29% of the examined cases.14 Because
there are immunological abnormalities in PH associ-
ated with CTD, immunosuppressive therapy leads to
a moderate improvement of the condition.15,16
Further, MCTD patients exhibit significantly
higher AECA,6 which is also found in other CTD.17,18
AECA in the serum stimulates the production of en-
dothelin that is related to vascular damage in patients
with SLE.19 We are now studying these pathways to
elucidate the antigens that give rise to AECA. Such
antigens may have applications in the treatment of
PH.
Recently, several drugs have been developed for
treatment of PH, particularly for PH associated with
CTD. They targets of the drugs are biologically re-
lated to prostacyclin, endothelin, and phosphodi-
esterase type 5, which may be involved in vascular
damage.20 Further studies are needed to reveal their
actual effects on the lesions.
Pulmonary Hypertension in CTD
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